Loading...

Treprostinil Dependence And Litigation Risks Will Undermine Long Term Pulmonary Hypertension Prospects

Published
22 Dec 25
Views
26
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
165.4%
7D
-2.6%

Author's Valuation

US$16.99153.4% overvalued intrinsic discount

AnalystLowTarget Fair Value